Shift Pharmaceuticals
PrivateLast Round
Grant
Jul 24, 2018
Total Funding Raised
$3M
Company Overview
Shift Pharmaceuticals operates in Healthcare & Life Sciences and is based in Columbia, Missouri. Its latest recorded funding round was a Grant round in July 2018.
Shift Pharmaceuticals is a biotechnology company that develops antisense oligonucleotide-based therapeutics for the treatment of neuromuscular and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shift Pharmaceuticals Comparables
Compare Shift Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Armatus Bio | 87% | |
| SQY Therapeutics | 79% | |
| Nervosave Therapeutics | 78% |
For institutional investors. Book with your work email.
Shift Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shift Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Congressionally Directed Medical Research Programs | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2025
Monthly visitors increased 1083% MoM, reaching 1.1K.
- Jul 24, 2018
$3M grant from Congressionally Directed Medical Research Programs and NIH.
For institutional investors. Book with your work email.
Shift Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shift Pharmaceuticals's valuation, stock price, and market status.
Is Shift Pharmaceuticals a public or private company?
Shift Pharmaceuticals is a private company.
What is the current stock price of Shift Pharmaceuticals?
Shift Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Shift Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shift Pharmaceuticals worth (valuation)?
Valuation information for Shift Pharmaceuticals is not publicly available.
Can I buy Shift Pharmaceuticals stock?
Shift Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shift Pharmaceuticals's last funding round?
Shift Pharmaceuticals's most recent funding round was Grant on July 24, 2018.
Who are the main investors in Shift Pharmaceuticals?
Key investors in Shift Pharmaceuticals include Congressionally Directed Medical Research Programs, National Institutes of Health (NIH).
Will Shift Pharmaceuticals IPO soon?
No public IPO plans have been announced for Shift Pharmaceuticals.
How can I track Shift Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Shift Pharmaceuticals's shares on secondary markets.